Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $359.30 million. The enterprise value is $161.58 million.

Market Cap	359.30M
Enterprise Value	161.58M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

RCKT has 108.22 million shares outstanding. The number of shares has increased by 14.70% in one year.

Current Share Class	108.22M
Shares Outstanding	108.22M
Shares Change (YoY)	+14.70%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	2.75%
Owned by Institutions (%)	66.84%
Float	78.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.15
P/TBV Ratio	1.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.30, with a Debt / Equity ratio of 0.08.

Current Ratio	7.30
Quick Ratio	7.15
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-130.71

Financial Efficiency

Return on equity (ROE) is -74.88% and return on invested capital (ROIC) is -44.51%.

Return on Equity (ROE)	-74.88%
Return on Assets (ROA)	-40.56%
Return on Invested Capital (ROIC)	-44.51%
Return on Capital Employed (ROCE)	-73.38%
Revenue Per Employee	n/a
Profits Per Employee	-$805,726
Employee Count	299
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.55% in the last 52 weeks. The beta is 0.65, so RCKT's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-75.55%
50-Day Moving Average	3.41
200-Day Moving Average	4.56
Relative Strength Index (RSI)	51.70
Average Volume (20 Days)	2,008,638

Short Selling Information

The latest short interest is 11.56 million, so 10.68% of the outstanding shares have been sold short.

Short Interest	11.56M
Short Previous Month	11.03M
Short % of Shares Out	10.68%
Short % of Float	14.63%
Short Ratio (days to cover)	4.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-247.18M
Pretax Income	-240.91M
Net Income	-240.91M
EBITDA	-236.01M
EBIT	-247.18M
Earnings Per Share (EPS)	-$2.24

Full Income Statement

Balance Sheet

The company has $222.76 million in cash and $25.05 million in debt, giving a net cash position of $197.71 million or $1.83 per share.

Cash & Cash Equivalents	222.76M
Total Debt	25.05M
Net Cash	197.71M
Net Cash Per Share	$1.83
Equity (Book Value)	313.67M
Book Value Per Share	2.90
Working Capital	196.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$202.12 million and capital expenditures -$669,000, giving a free cash flow of -$202.79 million.

Operating Cash Flow	-202.12M
Capital Expenditures	-669,000
Free Cash Flow	-202.79M
FCF Per Share	-$1.87

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.70%
Shareholder Yield	-14.70%
Earnings Yield	-67.05%
FCF Yield	-56.44%

Dividend Details

Analyst Forecast

The average price target for RCKT is $29.12, which is 777.11% higher than the current price. The consensus rating is "Buy".

Price Target	$29.12
Price Target Difference	777.11%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.46%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2